12月8日增减持汇总：西藏药业等3股增持药明康德等11股减持（表）

新浪证券12-18

　　炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！

　　据统计，12月18日，盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。

新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。

海量资讯、精准解读，尽在新浪财经APP

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2592890154?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-18 21:59","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2592890154","market":"hk","top_or_hot":-1,"title":"12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）","media":"新浪证券","content":"<html><body><div>\n<blockquote><p>　　炒股就看<a href=\"https://laohu8.com/S/603586\">金麒麟</a>分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！</p></blockquote> <p>　　据统计，12月18日，盘后<span><a href=\"https://laohu8.com/S/001203\">大中矿业</a></span><span></span>、<span><a href=\"https://laohu8.com/S/600039\">四川路桥</a></span><span></span>、<span><a href=\"https://laohu8.com/S/600211\">西藏药业</a></span><span></span>披露增持情况。包括<span><a href=\"https://laohu8.com/S/605365\">立达信</a></span><span></span>、<span><a href=\"https://laohu8.com/S/603259\">药明康德</a></span><span></span>、<span><a href=\"https://laohu8.com/S/002536\">飞龙股份</a></span><span></span>、<span><a href=\"https://laohu8.com/S/301273\">瑞晨环保</a></span><span></span>、<span><a href=\"https://laohu8.com/S/300694\">蠡湖股份</a></span><span></span>、<span><a href=\"https://laohu8.com/S/688180\">君实生物</a></span><span></span>、<span><a href=\"https://laohu8.com/S/301123\">奕东电子</a></span><span></span>、<span><a href=\"https://laohu8.com/S/688535\">华海诚科</a></span><span></span>、<span>博硕科技</span><span></span>、<span><a href=\"https://laohu8.com/S/301042\">安联锐视</a></span><span></span>、大中矿业在内的11家A股上市公司披露减持情况。</p>\n<div><img src=\"http://n.sinaimg.cn/finance/transform/678/w550h128/20251218/a4d6-d019d6d4e4810bc06a35aa718d86c9ff.png\"/><span></span></div>\n<div><img src=\"http://n.sinaimg.cn/finance/transform/116/w550h366/20251218/8666-e0aa6521883e4364288196032ea2058d.png\"/><span></span></div>\n<div></div>\n<font>新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。</font>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">新浪证券</strong><span class=\"h-time small\">2025-12-18 21:59</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<blockquote><p>　　炒股就看<a href=\"https://laohu8.com/S/603586\">金麒麟</a>分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！</p></blockquote> <p>　　据统计，12月18日，盘后<span><a href=\"https://laohu8.com/S/001203\">大中矿业</a></span><span></span>、<span><a href=\"https://laohu8.com/S/600039\">四川路桥</a></span><span></span>、<span><a href=\"https://laohu8.com/S/600211\">西藏药业</a></span><span></span>披露增持情况。包括<span><a href=\"https://laohu8.com/S/605365\">立达信</a></span><span></span>、<span><a href=\"https://laohu8.com/S/603259\">药明康德</a></span><span></span>、<span><a href=\"https://laohu8.com/S/002536\">飞龙股份</a></span><span></span>、<span><a href=\"https://laohu8.com/S/301273\">瑞晨环保</a></span><span></span>、<span><a href=\"https://laohu8.com/S/300694\">蠡湖股份</a></span><span></span>、<span><a href=\"https://laohu8.com/S/688180\">君实生物</a></span><span></span>、<span><a href=\"https://laohu8.com/S/301123\">奕东电子</a></span><span></span>、<span><a href=\"https://laohu8.com/S/688535\">华海诚科</a></span><span></span>、<span>博硕科技</span><span></span>、<span><a href=\"https://laohu8.com/S/301042\">安联锐视</a></span><span></span>、大中矿业在内的11家A股上市公司披露减持情况。</p>\n<div><img src=\"http://n.sinaimg.cn/finance/transform/678/w550h128/20251218/a4d6-d019d6d4e4810bc06a35aa718d86c9ff.png\"/><span></span></div>\n<div><img src=\"http://n.sinaimg.cn/finance/transform/116/w550h366/20251218/8666-e0aa6521883e4364288196032ea2058d.png\"/><span></span></div>\n<div></div>\n<font>新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。</font>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.sina.com.cn/stock/marketresearch/2025-12-18/doc-inhcfvmc8319448.shtml\">新浪证券</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-18/doc-inhcfvmc8319448.shtml","article_id":"2592890154","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592890154","pubTimestamp":1766066340,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　据统计，12月18日，盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。\n\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600211":"西藏药业","603259":"药明康德","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","02359":"药明康德","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","BK0033":"西藏振兴","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","BK0239":"医药制造","BK1583":"高瓴概念","BK0216":"研究试验","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK1141":"生命科学工具和服务","LU1997245177.USD":"安联神洲A股基金","BK1576":"医药外包概念","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC"},"translate_title":"Summary of increases and decreases in holdings on December 8: 3 shares including Tibet Pharmaceutical increased their holdings and 11 shares including WuXi AppTec decreased their holdings (table)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600211":1.5,"603259":1.5,"02359":1.5},"content_text":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　据统计，12月18日，盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。\n\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592890154","isCrawlerRequest":true}

12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）

精彩评论

12月8日增减持汇总：西藏药业等3股增持药明康德等11股减持（表）